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Environmental Influences on the
Immune System and
Allergic Reactions
by N. Franklin Adkinson, Jr.*
Environmental interactions with the immune system may result in two types of adverse outcomes:
immunodeficiency and immunopathology. Serious immunodeficiency most commonly results from ioniz-
ing radiation or as a recognized side effect of iatrogenic drug therapy, usually cancer chemotherapy. At
present there is little basis for believing that biologically significant suppression ofimmune competence in
man results from more subtle interactions with environmental agents. On the other hand, environmen-
tally triggered immunopathology is a source ofconsiderable morbidity and mortality. Additional research
is needed in the following areas: (a) basic mechanisms ofimmunopathological reactions; (b) development
of methods for accurately implicating or excluding immunological mechanisms in the etiology of
hypersensitivity states; (c) development ofmethods for assessing in advance the potential immunogenicity
ofnew industrial chemicals and occupational allergens; (d) identification ofthe risk factors which predis-
pose to immunopathological outcomes when individuals are exposed to sensitizing chemicals or other
"natural" allergens.
Introduction
The immune system allows an organism to dis-
criminate "self" from "non-self." In a broad
sense, an individual's environment may be defined
as the sum of experiences which are "non-self."
The immune system provides the individual with a
specific memory of past environmental interac-
tions. In addition, homeostatic effector
mechanisms within the immune system protect the
individual from potentially deleterious environmen-
tal interactions. These mechanisms are best under-
stood with regard to the protective immunity in-
duced by exposure to infectious agents. The im-
mune system also provides a triggering mechanism
for inflammatory processes which result in isolation
and elimination of noxious foreign substances or
damaged host tissue. It may also play an important
role in constant surveillance for and elimination of
neoplastic growths.
Environmental interaction with the immune sys-
tem may result in undesirable effects of two princi-
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pal types. If environmental hazards succeed in
damaging the immune system functionally, a rela-
tive state of immunodeficiency may result. Im-
munodeficiency, ifsevere, can be life-threatening in
that an important biological defense system is ren-
dered inactive. Occasionally, the immune system,
designed by evolution to be ofoverall benefit to the
individual, is nevertheless capable of mediating
harmful pathological processes. The particular cir-
cumstances which favor the development of self-
destructive immunopathology are largely unknown.
Whereas severe immunodeficiency states are un-
common, immunopathological processes are known
or suspected to play a role in a large number of
disease states.
This presentation attempts a limited review of
significant aspects of environmentally-induced im-
munodeficiency and immunopathology. It does not
attempt analysis of every conceivable environmen-
tal interaction with the immune system, but rather
focuses upon interactions which meet three re-
quirements: (1) the environment-immune system in-
teraction is common enough to have potential im-
pact on the public health; (2) there remain unan-
swered research questions of crucial importance to
the development ofsolutions which may ameliorate
the problem; and (3) the problem is not likely to be
dealt with by other members of the Task Force.
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on Immunologic Competence
Physical and Chemical Agents
It has been long recognized that appreciable
doses of ionizing radiation may result in im-
munodeficiency states of various degrees. The ef-
fects of nonionizing electromagnetic radiation in-
cluding microwave transmission are less well
studied. At present there is no reason to suspect
that the routine use ofroentgenography in medicine
or dentistry or radiation exposure from appliances
such as color television sets and microwave ovens
caln induce significant states of immunodeficiency.
This is not to say, however, that there are no unde-
sirable biological effects resulting from these ex-
posures.
Chemical toxins such as benzenes and toluenes
can produce various degrees of bone marrow sup-
pression which occasionally may be irreversible.
Severe bone marrow aplasia is often accompanied by
some degree of immunodeficiency, depending upon
the age of the individual and the spectrum of bone
marrow-derived cells affected. In most cases, the
hemopoietic deficit is paramount and responsible in
large part for the associated morbidity and mortal-
ity. Not all individuals are equally susceptible to the
effects of such chemical toxins; the basis for sus-
ceptibility or resistance is unknown.
Drugs of a variety of types can induce immune-
deficient states. The best examples of this are the
antineoplastic drugs which possess generalized
cytotoxicity, in which effects the cellular elements
of the immune system share. In general, rapidly
proliferating cells are affected to a greater degree,
and long-lived small lymphocytes which carry im-
munologic memory may be relatively spared. The
malignant process for which the drug is given is the
chief concern. In patients "cured" by cancer
chemotherapy, persistent immunological deficits
are rare, suggesting that the immunodeficiency
state is temporary. The same is true of patients
given immunosuppressive drugs in order to render
them tolerant to a homograft. In this case, some
degree of immunological incompetency of the host
is the desired effect achieved by drug administra-
tion.
In recent years, increasing use has been made
of immunosuppressive drugs in perilous clinical
disorders where chronic immunopathological
mechanisms are suspected. Such disease states in-
clude rheumatoid arthritis and systemic lupus
erythematosus, both commonly considered "auto-
immune" diseases. It has recently become ap-
preciated that excessive activity of a subset of lym-
phocytes whose normal function is to suppress or
regulate the overall immune response may be an im-
portant mechanism in some "autoimmune" states,
and in some immunodeficiency diseases as well.
Immunosuppressive chemotherapy aimed specifi-
cally at this hyperactive lymphocyte population may
be more extensively employed in future medical
therapy.
The effects of immunosuppressive drugs on vari-
ous arms ofthe immune system has been studied but
the general basis for their efficacy is still poorly un-
derstood. For example, the role of partial im-
munosuppression in the beneficial antiinflammatory
effects of high doses of corticosteroids is still un-
known. In addition, antimicrobial drugs such as
rifampin and amantadine, which were not designed
to achieve immunosuppression, have, nevertheless,
been found to have significant influences on immune
competence. No doubt other drugs with unexpected
side effects affecting the immune system will be de-
veloped in the future, and these may be ofbenefit in
selectively altering immune capabilities in medical
disease states where this may appear desirable. In
general, however, drug effects on the immune sys-
tem are routinely studied as part of the vigorous re-
quirements for new drug applications. Whether
drugs now commonly in use, including patent medi-
cations, are capable of altering immune capabilities
in certain individuals has not been systematically
evaluated, but currently there seems no reason to
suspect that this presents a significant problem.
Increasing evidence raises the possibility that
chronic, subclinical exposure to certain chemicals of
en\'ironmental concern such as heavy metals and
halogenated hydrocarbons may depress immune re-
sponsiveness ani in some cases increase susceptibil-
ity to infectious ageXnts in experimental animals (1).
The relevance of these observations for human dis-
e;ase is currently unknown but deserves further exp-
loration.
General Pollutants and Psychosocial Stress
Experimental studies of "dirty" environments
using laboratory animals have failed to demonstrate
any adverse effect of such environments on either
the development ofthe immune system, its degree of
competence, or the decline of immune capability
with age (2). In fact, some animal studies have sug-
gested that "dirty" environments actually facilitate
antibody formation, presumably by some form ofad-
juvant effect (3). The influence on immune compe-
tency of social factors such as overcrowding and
other types ofpsychological stress has been the sub-
ject of psychosomatic research (4). In general such
research has shown that stressed animals are more
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infections and neoplasms. Whether these biological
effects can be explained totally on the basis of im-
pairment of immunological competence seems un-
likely but warrants further study.
Research Needed
With regard to the ability ofenvironmental agents
to induce immunodeficiency, there are not, in the
opinion of this author, general lapses in knowledge
which warrant majorproject-directed efforts. We are
aware that drugs, chemicals, ionizing radiation, and
stress in sufficient quantity will impair immune func-
tion. This knowledge has been exploited in some
medical circumstances to render beneficial effects.
More subtle influences of environmental agents on
immune capability, though quite conceivable and
perhaps even likely, do not at this time appear to
impair the biological fitness ofmost individuals. The
resiliency of the immune system to environmental
stress appears to be great, as mightbe expected since
its principal evolutionary function is to protect the
individual from environmental insults. Nevertheless,
studies ofthe effect ofchronic low-dose exposure to
environmental agents on immune responsiveness
siiould be pursued in carefully selected areas. Such
areas include studies of physical and chemical ag-
ents, including drugs for which there is some indica-
tion ofselective toxicity for the immune system, and
evaluation ofclinical states ofincreased susceptibil-
ity to infection or increased incidence of cancers of
multiple origin where the possibility ofenvironmen-
tal induction exists (e.g., "epidemics" of multiple
infections or neoplastic diseases in industrial set-
tings.)
Environmentally-induced
Adverse Immunological
Reactions
Scope of the Problem
Immunopathological mechanisms contribute sub-
stantially to human mortality and morbidity. The cir-
cumstances under which the immune system can in-
flict pathological damage are myriad (5). The
pathological process may be relatively organ-specific
(e.g., allergic asthma, contact dermatitis) or mul-
tisystem (e.g., anaphylaxis, immune complex dis-
ease). Apparently, no tissue is entirely safe from
immune-inflicted damage. Even the central nervous
system and the anterior chamber of the eye, long
thought to be relatively isolated from immunologi-
cally competent cells, now clearly can be the site of
immunopathological damage. Which tissue or organ
system is affected by immunopathological
mechanisms depends upon numerous factors.
Among these are the route ofentry and distribution
of the antigen, the metabolic state of the organism,
overall immunological competence, and in many
cases factors which have not been clearly identified.
Gell and Coombs (6) have proposed a classifica-
tion of immunopathological mechanisms (see Table
1). This classification ignores much ofwhat has been
learned in recent years conceming the intricacies of
the mechanisms, particularly the variety of
mechanisms by which thymus-derived lymphocytes
may inflict tissue injury. The classification also over-
simplifies by omitting the complex interactions of
these mechanisms which often amplify or attenuate
one another. Rarely is one of these mechanisms
operative in total isolation from the others.
Nevertheless, the classification is useful didactically
in categorizing the principal mechanisms now known
by which the immune system can inflict injury.
A single environmental agent may be capable of
initiating any or all of these mechanisms. A ready
example of this is provided by allergic drug reac-
tions. An immunological response againstpenicillin
may result inanaphylaxis orurticaria (type I) in one
patient, hemolytic anemia (type II) in a second pa-
tient, serum sickness (type III) inanother, and con-
tact dermatitis (type IV) in yet anotherpatient. The
variables that determine which pathological process
is manifest in given individuals are poorly under-
stood.
Furthermore, it becomes important to appreciate
that, while an immune response to aforeign antigen
is necessary, it is not in and of itself sufficient for
the initiation of immunopathological processes.
This is again well illustrated from studies ofpenicil-
lin hypersensitivity (7). We now know that the vast
majority ofpatients who receive penicillin drugs re-
spond immunologically to the drug-protein com-
plexes which normally form under physiological
conditions; yet only a very small percentage of
those who respond immunologically to penicillin
administration exhibit any adverse reaction to the
drug. There appear to be, therefore, individual risk
factors, some ofwhichareunrelatedtotheabilityto
engender an immune response against penicillin,
which may be principal determinants ofrisk ofim-
munopathological reactions to the drug. Except for
the minimal influences ofage and atopic status, the
individual risk factors which predispose to penicil-
lin allergy are unknown. Penicillin hypersensitivity
provides our best studied example of sensitization
by small molecular weight drugs and chemicals.
With regard to other drugs, most industrial and oc-
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Gell and
Coombs type Description Mechanism(s) Clinical examples
Anaphylactic IgE mediated non-cyto- Anaphylaxis
hypersensitivity toxic mediator re- Urticaria
(reaginic allergy) lease from basophilic "Extrinsic" asthma
leukocytes and tissue Allergic rhinocon-
mastcells junctivitis
11 Cytolysis or cyto- Complement mediated Rh hemolytic disease
toxic damage injury involving ofthe newborn
antibodies (IgM and Interstitial nephritis
IgG) and any cell Some drug-induced
with iso-antigen cytopenias
Goodpasteur's syndrome
III Immune complex Complement-mediated Serum sickness
inflammatory re- SLE nephritis
sponse initiated by Drug fever
soluble antigen- Some glomerulonephritis
antibody complexes
(mainly IgG)
IV "Delayed" or Injury directly (cyto- Contact dermatitis
cellular hyper- lysis) and indirectly Tuberculin hypersensi-
sensitivity (lymphokines) from tivity
sensitized small Allograft rejection
lymphocytes and Tumor immunity
macrophages
cupational allergens, and infectious agents little or
nothing is known of the risk factors for im-
munopathology. This is in contradistinction to cer-
tain "natural" aeroallergens such as pollens, animal
danders, fungi, and organic dusts where an inher-
ited constitutional substrate commonly called
"atopy" is a major but not the sole predisposing
factor (8).
In summary, the problem of sensitivity to en-
vironmental agents is more complex from the point
of view of preventive medicine than it initially ap-
pears. It is not, as originally assumed, simply a mat-
ter ofidentifying and minimizing exposure to those
environmental agents which are immunogenic in
man. Since only a small number of those patients
who respond immunologically to an environmental
agent will suffer any ill consequences from that en-
counter, it becomes necessary to focus upon the
risk factors which predispose to actual im-
munopathology. These may be either environmen-
tal factors (e.g., the intensity and duration of ex-
posure to the environmental agent) or individual
risk factors endogenous to the organism (e.g., ge-
netic factors controlling immune responsiveness,
metabolic processing of antigen, and the "atopic"
diathesis; coexisting disease states, metabolic aber-
rations, etc.).
Prototypes ofEnvironmental Sensitization
Environmental agents which can sensitize individ-
uals for allergic (immunologic) responses fall into
two major categories. First, large molecular weight
foreign protein or carbohydrate substances may in-
itiate an immune response directly; these substances
are usually immunogenic but only occasionally al-
lergenic. Examples of "complete" antigens which
are highly immunogenic in man include bacterial and
viral antigens, heterologous antisera, and biological
pollens and spores. Many known factors contribute
to the degree ofimmunogenicity ofthese substances;
these include dose and frequency of exposure, de-
gree of immunological "foreignness" (not-self),
genetic factors within the host controlling immune
recognition and responsiveness, and intrinsic
physical-chemical properties ofthe antigen itself(9).
Prototypes of the sensitizing mechanisms for these
''complete" environmental antigens include the
classic studies of experimental serum sickness in
animals (10); and in man, the well studied examples
of IgE-mediated pollenosis (allergic rhinitis and
asthma) (11) and the industrial case of sensitivity to
bacterial enzymes formerly added to some de-
tergents (12).
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1000 are generally not capable ofeliciting an immune
response in and ofthemselves. Only those drugs and
chemicals which are capable of covalent linkage to
carrier molecules (usually proteins) are im-
munogenic. Classic studies done many years ago
have established that those chemicals which can
covalently link to and thus "haptenize" autologous
protein in host tissue are capable of sensitizing the
host (13). Furthermore, the frequency of sensitivity
observed in vivo is directly correlated with the pro-
tein reactivity ofachemical as demonstrated in vitro.
The prototype for the immunogenicity of simple
chemicals in man is penicillin hypersensitivity,
where considerable immunochemical and clinical in-
formation had been acquired (7).
Categories ofOffending Environmental
Allergens
A large number of natural and man-made sub-
stances are capable ofoffending the human organism
in a variety ofways. In fact, it is difficult to think of
any environmental substance which cannot be toxic
or noxious under certain circumstances. Even essen-
tial elemental ingredients such as oxygen can be
toxic. When an individual becomes sensitive to a
substance which most others tolerate at the same
dosage with impunity, we correctly refer to this as
"hypersensitivity." "Allergy" is understood by
many laymen and professionals alike to be
synonymous with hypersensitivity. Because of this
semantic equation, numerous hypersensitivity states
have been presumed without evidence to be im-
munologic in origin.
Table 2 presents a partial list of environmental
allergens capable of inducing adverse reactions
which may be mediated by immunological
mechanisms. There are a large number of sub-
stances, particularly drugs (e.g., aspirin), which can
elicit reactions in susceptible patients which appear
clinically to represent allergic responses, but which
are quite likely to have other nonimmunologic
mechanisms. Making a clear distinction between
immunologic and nonimmunologic mechanisms for
adverse reactions to environmental agents is impor-
tant, since the prophylaxis ofthese reactions as well
as their management maydepend heavily upon such
knowledge.
Many "natural" substances which are potential
allergens are essentially ubiquitous. Although ex-
posure to plant pollens, fungal spores, and pollutant
organic dusts may vary considerably in various lo-
cations, there are few geographic sites where sus-
ceptible individuals can avoid exposure to al-
lergenic substances altogether. Allergic reactions to
some ofthese materials (particularly pollens, fungi,
and foods) are clinically associated with the
"atopic" trait. However, other important risk fac-
tors are clearly involved and require exploration.
Adverse effects associated with immunological re-
sponses to infectious agents, especially viruses, are
clearly established in certain cases (e.g., subacute
sclerosing panencephalitis), and suspected as con-
tributing factors in others (various demyelinating
diseases, and systemic lupus erythematosus).
Whether less severe and more subtle consequences
of viral and bacterial infections (e.g., bronchospasm
inassociation with intercurrent viral infections; and
cutaneous eruptions associated with numerous infec-
tious states) are immunologically mediated requires
further study.
Table 2. Some environmental allergens capable of inducing im-
munopathological states
"Natural" allergens
Aeroallergens: pollens, animal danders, organic dusts,
fungal spores, infectious agents
Contactants: poison ivy (oleoresin), infectious agents
Injectants: stinging insect venoms
Ingestants: foods, infectious agents including parasites
Occupational allergens
Bird fancier's lung (serum proteins in droppings)
Hypersensitivity pneumonitis due to variety oforganic dusts
Molds and particulates (e.g., cotton fibers)
Industrial chemical allergens
Detergent enzymes
Heavy metal salts
Toluene diisocyanate (TDI)
Phthalic acid anhydride
Piperazines
Exoxy resins
Soldering flux
Polyvinyl chloride (PVC) fumes
Drugs, patent medicine, food additives, cosmetics
Penicillins
Cepholosporins
Quinidine
Sulfonamides
Antituberculous drugs
Local anesthetics
Phenolphthalein
Antithyroid drugs
Insulin
Photosensitizing chemicals
Fragrance chemicals
Preservatives and stabilizers
Food additives
Occupational and industrial allergens have been
recognized with increasing frequency in recent years
(14). Most commonly, these are aeroallergens and
produce a pneumonitis usually designated extrinsic
allergic alveolitis. Depending upon particle size and
the intensity and duration of exposure, various or-
ganic dusts and their microorganismal flora can
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susceptible individuals. Most afflicted individuals
have nonatopic backgrounds. The immu-
nopathological mechanism is felt to be predom-
inantly a type III, but the participation of a type IV
process cannot be excluded. When extrinsic al-
veolitis occurs in atopic individuals, an additional
IgE-mediated (type I) mechanism may also be of
importance. In most of these disorders, the fre-
quency of disease increases with increasing inten-
sity of exposure, although other individual risk fac-
tors are clearly important. For example, still unex-
plained is why pigeon breeder's disease occurs i'
less than 5% of pigeon fanciers and why baker's
asthma is a rarity among bakers.
Chemical allergens arising from industrial expos-
ure usually inflict immunopathology upon only a
small subset of workers who are hypersusceptible
to the low dose exposure which is legally allowable
in chemical plants. Since most immunological pro-
cesses like toxicological ones are dose-related to
some degree, it is not surprising that the establish-
ment of maximum allowable concentrations to
which industrial chemical workers can be legally
exposed has resulted in significant reduction in
morbidity. On the other hand, from 1 to 10% of
industrial workers exposed to legally permissible
levels of organic isocyanates will subsequently de-
velop hypersensitivity reactions following low dose
exposure to the chemicals (15). Similarly, a small
group of highly susceptible workers becomes im-
munologically sensitive when exposed to numerous
other industrial chemicals, including various syn-
thetic resins, piperazine derivatives, penicillin salts,
soldering fumes, heavy metal salts (especially
platinum, beryllium, and chromium), industrial
dyes, and many cosmetic and perfume ingredients
(16). In almost all of these cases, it has been possi-
ble to identify a chemical which is highly protein-
reactive and thought likely to be the principal of-
fending allergen. When sensitized, many industrial
workers cannot continue to tolerate even very low
levels of further exposure. This has resulted in a
considerable industrial medicine problem, one re-
sult of which has been an effort by industry to de-
velop methods for identifying the hypersusceptible
worker in advance (17). However, with very few
important exceptions this has not yet become pos-
sible. Despite the absence of convincing evidence
that an atopic background carries an increased risk
of developing chemical sensitivity, it has become a
common industrial practice to exclude such indi-
viduals arbitrarily from employment in industrial
chemical industries.
Food preservatives and additives are clearly cap-
able of inducing hypersensitivity reactions in sus-
ceptible individuals (18). Presently it seems doubt-
ful that these are on the basis of immunologic reac-
tions. However, additional study is needed not only
ofthe mechanisms involved but ofthe susceptibility
factors which predispose to these reactions.
Research Needed
Research on environmentally induced im-
munopathology must continue to be multifaceted.
Where immunological mechanisms are implicated,
the precise details ofthe pathological processes de-
serve exploration. Of greater short-range impor-
tance, however, would be the development of
methods which would allow rapid assessment of
whether a hypersensitivity reaction is mediated by
an immunological mechanism. This becomes im-
portant in order to stimulate the search for alterna-
tive explanations in those cases of adverse reactiv-
ity where no immunological mechanisms can be im-
plicated. As but one example, the study of aspirin
sensitivity was long retarded by the unfounded as-
sumption that the reactions were immunologic in
origin. Now that this illusion has been removed,
considerable progress is being made toward a better
understanding ofits biochemical basis.
For industrial and occupational hypersensitivity
diseases, research efforts should be aimed at de-
veloping methods for predicting in advance the
likely allergenicity of industrial chemicals so as to
minimize from the very start worker and consumer
exposure to these chemicals. Technical research is
also needed to develop more effective and better
tolerated methods of removing sensitizing chemi-
cals from the inspired air of exposed employees.
Considerable priority should also be given to iden-
tification of the individual risk factors which singly
or collectively constitute the hypersusceptible
state. It is now clear that immunological status (in-
cluding an atopic background) is only one of
numerous potential riskfactors, and in most cases it
may play arelatively minorrole.
This material is drawn from a Background Document pre-
pared by the author for the NIEHS Second Task Force for
Research Planning in Environmental Health Science. The Re-
port of the Task Force is an independent and collective report
which has been published by the Government Printing Office
under the title, "Human Health and Environment-Some Re-
search Needs." Copies of the original material for this Back-
ground Document, as well as others prepared for the report can
be secured from the National Technical Information Service,
U.S. Department ofCommerce, 5285 Port Royal Road, Spring-
field, Virginia 22161.
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